Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

During yesterday’s trading session USD/CAD traded within the range of 1.0717-1.0754 and closed at 1.0732.

At 11:21 GMT today USD/CAD was losing 0.05% for the day to trade at 1.0728. The pair touched a daily low at 1.0716 at 8:10 GMT, the weakest since January 7th.

Fundamental view

Home values in 20 large cities throughout the United States probably rose at an annualized rate of 11.73% during April, preliminary experts’ estimates showed. In March, home prices climbed at a rate of 12.37%. S&P/Case-Shiller will release the official rate at 13:00 GMT.

At the same time, confidence among US consumers probably improved in June. The corresponding index probably rose to a reading of 83.5 from 83.0 in May. The Conference Board research group is to announce the results from its survey, encompassing over 5 000 households in the country, at 14:00 GMT. If the gauge of confidence shows a better than expected performance, this would certainly heighten the appeal of the US dollar.

Also at 14:00 GMT United States’ Census Bureau is to announce the results from the Survey of Construction, regarding sales of new, privately-owned residential buildings currently authorized by a building permit or started in areas not requiring a building permit in May. New home sales in the country probably jumped to 0.440 million last month from 0.433 million in May.

Technical view

Screenshot from 2014-06-24 14:26:54

According to Binary Tribune’s daily analysis, in case USD/CAD manages to breach the first resistance level at 1.0752, it will probably continue up to test 1.0771. In case the second key resistance is broken, the pair will probably attempt to advance to 1.0789.

If USD/CAD manages to breach the first key support at 1.0712, it will probably continue to slide and test 1.0695. With this second key support broken, the movement to the downside will probably continue to 1.0676.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Priceline.com jumps 5.7% after beating analysts’ estimatesPriceline.com jumps 5.7% after beating analysts’ estimates The worlide economic crisis last five years dont seem to reflect in Priceline.coms performance as its stock neared a $1,000 price and a record that was set during the dot-com bubble.Priceline, the largest U.S. online-travel agent by […]
  • USD/JPY preserves losses as Bank of Japan, Fed put monetary easing on holdUSD/JPY preserves losses as Bank of Japan, Fed put monetary easing on hold US dollar was losing ground against the Japanese yen on Thursday, after Bank of Japan (BoJ) maintained its unprecedented monetary stimulus at the policy meeting today, also reiterating that the rate of inflation in the country will almost […]
  • US stocks surge on $10 billion Fed taperingUS stocks surge on $10 billion Fed tapering U.S. stocks gained, sending benchmark indexes to all-time highs, after the Federal Reserve said it will reduce the pace of its monthly bond purchases mainly due to expressed confidence in the labor market recovery.The Standard & Poor’s […]
  • AUD/USD loses ground after Chinese manufacturing dataAUD/USD loses ground after Chinese manufacturing data Australian dollar traded lower against its US counterpart on Thursday, after a report showed that the final reading of HSBC manufacturing PMI for China was unchanged from the preliminary value in December.AUD/USD touched a session low at […]
  • Japan’s trade balance deficit rose during AprilJapan’s trade balance deficit rose during April It was reported earlier today, that deficit on Japans Trade Balance widened during April, as import grew at a higher rate than export. Deficit figure rose to 880 billion JPY during April from 364 billion JPY during the preceding month. It […]
  • Chromocell Therapeutics amends stock repurchase planChromocell Therapeutics amends stock repurchase plan Chromocell Therapeutics Corporation (NYSE: CHRO) said on Thursday that its Board of Directors had authorized an amendment to the company’s existing stock repurchase plan.Under the amendment, the total value of shares of common stock […]